Dr. Trehu is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
101 Hartwell Ave
Lexington, MA 02421Phone+1 781-538-4203- Is this information wrong?
Education & Training
Tufts Medical CenterFellowship, Hematology and Medical Oncology, 1990 - 1993
Inova Fairfax Medical CampusResidency, Internal Medicine, 1988 - 1989
MedStar Health/Georgetown University HospitalResidency, Internal Medicine, 1985 - 1988
New York University School of MedicineClass of 1985
Certifications & Licensure
MA State Medical License 1990 - 2023
Clinical Trials
- Study of a PD-1 Inhibitor (JTX-4014) in Subjects With Solid Tumor Malignancies Start of enrollment: 2018 Dec 06
Publications & Presentations
PubMed
- 15 citationsFirst-in-Human Phase I/II ICONIC Trial of the ICOS Agonist Vopratelimab Alone and with Nivolumab: ICOS-High CD4 T-Cell Populations and Predictors of Response.Timothy A Yap, Justin F Gainor, Margaret K Callahan, Gerald S Falchook, Russell K Pachynski, Patricia LoRusso, Shivaani Kummar, Geoffrey T Gibney, Howard A Burris, Sco...> ;Clinical Cancer Research. 2022 Sep 1
- 67 citationsRecombinant human pentraxin-2 therapy in patients with idiopathic pulmonary fibrosis: safety, pharmacokinetics and exploratory efficacyBernt van den Blink, Marlous R. Dillingh, Leo C. Ginns, Lake Morrison, Matthijs Moerland, Marlies S. Wijsenbeek, Elizabeth G. Trehu, Brian J. Bartholmai, Jacobus Burgg...> ;The European Respiratory Journal. 2016 Mar 1
- 1 citationsHillmen Trial of Alemtuzumab in First-Line Chronic Lymphocytic Leukemia Still Provides Valuable InformationCynthia A. Sirard, Elizabeth G. Trehu> ;Journal of Clinical Oncology. 2008 May 10
- Join now to see all
Press Mentions
Jounce Therapeutics to Present Data from Its JTX-2011 and JTX-8064 Programs at the 2019 American Association for Cancer Research (AACR) Annual MeetingFebruary 27th, 2019- Jounce Therapeutics Presents Reverse Translational, Biomarker and Preclinical Data from ICOS Program at the Society for Immunotherapy of Cancer's (SITC) 33rd Annual MeetingNovember 10th, 2018
- Constellation Pharmaceuticals Announces Third-Quarter and Nine-Month 2018 Financial ResultsNovember 8th, 2018
- Join now to see all
Grant Support
- Phase III Comparison Hepatic Therapeutic Embolization VS Arterial ChemotherapyNational Center For Research Resources1995–1997
- Phase I Trial Of Verapamil And Chemoembolization In Hepatocellular CarcinomaNational Center For Research Resources1995–1996
Hospital Affiliations
- Beth Israel Deaconess Hospital-PlymouthPlymouth, Massachusetts
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
